Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection

• Главные авторы: Lorenza Romani (Автор), Francesca Ippolita Calò Carducci (Автор), Sara Chiurchiù (Автор), Laura Cursi (Автор), Maia De Luca (Автор), Martina Di Giuseppe (Автор), Andrzej Krzysztofiak (Автор), Laura Lancella (Автор), Paolo Palma (Автор), Leonardo Vallesi (Автор), Tiziana Corsetti (Автор), Andrea Campana (Автор), Emanuele Nicastri (Автор), Paolo Rossi (Автор), Stefania Bernardi (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2022-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Monoclonal antibody therapies for COVID-19 have been frequently used in adults, whereas there are little data regarding the safety or efficacy of monoclonal antibody treatments in pediatric patients affected by COVID-19. We report our experience in the administration of mAb as a treatment for SARS-C...